Impax Laboratories, LLC – Plans of Reorganization, Merger, Acquisition or Similar Watch

from 425 83 pages Amendment No. 2 to the Business Combination Agreement

from 8-K 83 pages Amendment No. 2 to the Business Combination Agreement

from 425 170 pages Amendment No. 1 to the Business Combination Agreement

from 8-K 170 pages Amendment No. 1 to the Business Combination Agreement

from 8-K 352 pages Business Combination Agreement Dated as of October 17, 2017 by and Among Impax Laboratories, Inc., Atlas Holdings, Inc., K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC

from 425 352 pages Business Combination Agreement Dated as of October 17, 2017 by and Among Impax Laboratories, Inc., Atlas Holdings, Inc., K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC

from 8-K 133 pages Stock Purchase Agreement by and Among Tower Holdings, Inc., Lineage Therapeutics Inc., Roundtable Healthcare Partners II, L.P., Roundtable Healthcare Investors II, L.P., and the Other Stockholders, Optionholders and Warrantholders Party Hereto, as Sellers, Impax Laboratories, Inc., as Buyer, Roundtable Healthcare Management II, LLC, (Solely With Respect to Section 8.3) and Roundtable Healthcare Partners II, L.P., as the Stockholder Representative Dated as of October 8, 2014

from SC 13D/A ~5 pages Plan of reorganization, merger, acquisition or similar

from SC 13D/A ~20 pages Securities Purchase Agreement

from SC 13D/A ~20 pages Plan of reorganization, merger, acquisition or similar

from SC 13D/A ~20 pages Stock Purchase Agreement

from SC 13D/A ~50 pages Stock Purchase Agreement

from 8-K >50 pages Plan of reorganization, merger, acquisition or similar